TransCode Therapeutics, Inc.

RNAZNASDAQ Capital Market·USD·Closed

RNAZNASDAQ·USD·Closed

$5.51

+10.64%

$5.51

+$0.53 (10.64%)

52W Range

10thpctl

Volume

0.37×avg

Mkt Cap

5.24MUSD

P/E

-0.1TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

10thpctl

Volume

0.37×avg

Market Cap

5.24MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-21.2%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-4942.7×

Current ratio3.11×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required